Brian Goodman, Ph.D.

Investment Team

Investment and Operations Team

Boston Office

Dr. Brian Goodman is a Partner at MPM, as well as a Partner of BioImpact Capital, an affiliate manager of MPM and manager of the Oncology Impact Funds, private/public funds focused on oncology as well as new modalities. Brian is a serial entrepreneur and is a co-founder of current MPM portfolio companies Aktis Oncology and ReNAgade Therapeutics. He also played key leadership roles in their early stages as Chief Operations Officer at Aktis Oncology and Head of Business Development at ReNAgade. Additionally, Brian led initial diligence on Orna Therapeutics, played an instrumental role in growing the company as VP of Business Development, and now serves as a member of the Board of Directors.

Previously, Brian co-founded Evelo Biosciences (NASDAQ: EVLO) and served as Head of Technology and Innovation. At Evelo, Brian led a team that established new programs to discover, formulate, and evaluate the pharmacology of microbial drugs across multiple therapeutic areas. He contributed to the in-licensing of foundational IP and forged collaborative research with multiple academic groups to complement Evelo’s internal research and development efforts. He is an inventor on multiple patent applications. Before taking the operational role at Evelo, Brian was a Senior Associate at Flagship Pioneering where he worked with the entrepreneurial division to build and launch new biotech ventures.

Brian holds a Ph.D. in Biological Chemistry and Molecular Pharmacology from Harvard Medical School, and B.S. and B.A. degrees in biochemistry and economics, respectively, from Brandeis University.